Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID) · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
immune-responserespiratory-syncytial-virus
respiratory syncytial virus, immune response, vaccine-mediated protection, neutralizing antibody, antibody response, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 915896
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.